{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:07:24Z","timestamp":1738732044019,"version":"3.37.0"},"reference-count":26,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S1047951124026787_as1\"><jats:title>Background:<\/jats:title><jats:p>Diastolic heart failure may be noted in paediatric patients with CHD, cardiomyopathy, or malignancies requiring chemotherapy, but the available data are scarce, and often derived from adult trials or based on theoretic or anecdotal evidence.<\/jats:p><\/jats:sec><jats:sec id=\"S1047951124026787_as2\"><jats:title>Methods:<\/jats:title><jats:p>Data between 2016 and 2021 were obtained from Pediatric Health Information System database. Patients &lt;18 years of age with isolated diastolic heart failure admitted to ICU at some point during admission were included. They were divided into patients with and without inpatient mortality. Patients\u2019 demographics, comorbidities using ICD-10 codes, and pharmacologic interventions were also recorded. Univariate analysis was done in demographics, comorbidities, pharmacologic interventions, and mechanical interventions between admissions with and without mortality. Multivariable logistic regression was done for inpatient mortality and multivariable linear regression was done for total hospital length of stay in survivors.<\/jats:p><\/jats:sec><jats:sec id=\"S1047951124026787_as3\"><jats:title>Results:<\/jats:title><jats:p>Isolated diastolic heart failure comprised 0.5% of critically ill paediatric patients. A total of 121 (5%) experienced mortality among the 2,273 admissions in the final analyses. Milrinone and angiotensin converting enzyme inhibitor were found to be associated with decreased mortality. Increasing age and diuretics were associated with decreased total hospital length of stay in survivors.<\/jats:p><\/jats:sec><jats:sec id=\"S1047951124026787_as4\"><jats:title>Conclusion:<\/jats:title><jats:p>In the cohort studied, isolated diastolic left heart failure has a 5% mortality. Several comorbidities and interventions are associated with increased mortality with milrinone and angiotensin converting enzyme inhibitors being associated with decreased risk of mortality. When only admissions with survival to discharge are considered, older age and diuretics are associated with lower total hospital length of stay.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s1047951124026787","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:47:34Z","timestamp":1730108854000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Comorbidities, pharmacologic interventions, and mechanical interventions associated with mortality in isolated diastolic left heart failure: lessons from a national database"],"prefix":"10.1017","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9116-2835","authenticated-orcid":false,"given":"Rohit S.","family":"Loomba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9731-2876","authenticated-orcid":false,"given":"Juan S","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-5192","authenticated-orcid":false,"given":"Enrique G.","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-5775","authenticated-orcid":false,"given":"Saul","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"S1047951124026787_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(98)01255-7"},{"key":"S1047951124026787_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw593"},{"key":"S1047951124026787_ref22","doi-asserted-by":"publisher","DOI":"10.1007\/BF00271056"},{"key":"S1047951124026787_ref24","first-page":"789","article-title":"Venous blood gases in pediatric patients: a lost art?","volume":"74","author":"Sheikholeslami","year":"2022","journal-title":"Minerva Pediatr (Torino)"},{"key":"S1047951124026787_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002963"},{"key":"S1047951124026787_ref21","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.athoracsur.2016.09.100","article-title":"Postoperative cerebral and somatic near-infrared spectroscopy saturations and outcome in hypoplastic left heart syndrome","volume":"103","author":"Hoffman","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"S1047951124026787_ref12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"10","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"S1047951124026787_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-020-00369-x"},{"key":"S1047951124026787_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"S1047951124026787_ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs141"},{"key":"S1047951124026787_ref13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"key":"S1047951124026787_ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002729"},{"key":"S1047951124026787_ref2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960241006"},{"key":"S1047951124026787_ref1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.73.4.340"},{"key":"S1047951124026787_ref25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"S1047951124026787_ref16","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12837"},{"key":"S1047951124026787_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi115"},{"key":"S1047951124026787_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000780"},{"key":"S1047951124026787_ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.846408"},{"key":"S1047951124026787_ref17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00246-021-02718-7","article-title":"Correlation of near-infrared spectroscopy oximetry and corresponding venous oxygen saturations in children with congenital heart disease","volume":"43","author":"Loomba","year":"2022","journal-title":"Pediatr Cardiol"},{"key":"S1047951124026787_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-022-00508-z"},{"key":"S1047951124026787_ref4","first-page":"37","article-title":"Systolic and diastolic function in congestive heart failure pediatric patients","volume":"54","author":"Butnariu","year":"2016","journal-title":"Rom J Intern Med"},{"key":"S1047951124026787_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.05.047"},{"key":"S1047951124026787_ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mhj.2002.120305","article-title":"Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics","volume":"143","author":"Hoffman","year":"2002","journal-title":"Am Heart J"},{"key":"S1047951124026787_ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.000175"},{"key":"S1047951124026787_ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908655"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951124026787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:10:46Z","timestamp":1738645846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951124026787\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1047951124026787"],"URL":"https:\/\/doi.org\/10.1017\/s1047951124026787","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"type":"print","value":"1047-9511"},{"type":"electronic","value":"1467-1107"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"\u00a9 The Author(s), 2024. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}